Formylcolchicine bound to lactosaminated serum albumin is a more active antifibrotic agent than free colchicine
Liver fibrosis was induced by chronically (7 weeks) administering CCl 4, to rats. Animals were divided into four groups: (a) controls, (b) treated with CCI, alone, (c) treated with CCl 4 and colchicine and (d) treated with CCl 4 and formyl-colchicine bound to lactosaminated serum albumin (FC-LASA)....
Saved in:
Published in | Clinica chimica acta Vol. 254; no. 2; pp. 149 - 157 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier B.V
29.10.1996
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Liver fibrosis was induced by chronically (7 weeks) administering CCl
4, to rats. Animals were divided into four groups: (a) controls, (b) treated with CCI, alone, (c) treated with CCl
4 and colchicine and (d) treated with CCl
4 and formyl-colchicine bound to lactosaminated serum albumin (FC-LASA). Liver dysfunction was monitored by biochemical tests (alkaline phosphatase [ALP], γ-glutamyltransferase [γGT], aspartate and alanine transaminases [AST and ALT], albumin and total bilirubin). Fibrosis was evaluated by determining hydroxyproline and by microscopic examination. The exposure to CCl
4 produced major alterations of liver structure and collagen deposition. These effects were partially counteracted by colchicine and to a greater extent by FC-LASA. Morphological findings paralleled biochemical data. The information reported here indicates that colchicine has an antifibrotic activity on the liver of intoxicated rats and that FC-LASA is more active than colchicine itself as an antifibrotic agent. |
---|---|
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/0009-8981(96)06381-4 |